These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6806488

  • 1. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [Abstract] [Full Text] [Related]

  • 2. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.
    Harrison GS, Green DF, Newling DW, Richards B, Robinson MR, Smith PH.
    Br J Urol; 1983 Dec; 55(6):676-9. PubMed ID: 6418263
    [Abstract] [Full Text] [Related]

  • 3. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 4. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H, Benson RC, Hilton JF, Taylor WF.
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [Abstract] [Full Text] [Related]

  • 5. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS.
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [Abstract] [Full Text] [Related]

  • 6. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
    MacFarlane JR, Tolley DA.
    Br J Urol; 1985 Feb; 57(1):37-9. PubMed ID: 3918605
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN, Nieh PT, Prout GR.
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [Abstract] [Full Text] [Related]

  • 12. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC, Ellison MF, Butler KM, Gomella LG, McRoberts JW.
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
    van Helsdingen PJ, Rikken CH, Sleeboom HP, de Bruyn EA, Tjaden UR.
    Urol Int; 1988 Jul; 43(1):42-6. PubMed ID: 3131943
    [Abstract] [Full Text] [Related]

  • 14. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
    Flüchter SH, Bichler KH, Harzmann R, Erdmann D.
    Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
    [Abstract] [Full Text] [Related]

  • 15. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC, Badalament RA, Lucas J, Drago JR.
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [Abstract] [Full Text] [Related]

  • 16. Renal failure after intravesical mitomycin C.
    Farha AJ, Krauss DJ.
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [Abstract] [Full Text] [Related]

  • 17. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS, Jordan AM, Murphy WM.
    Prog Clin Biol Res; 1989 Oct; 310():215-36. PubMed ID: 2505268
    [Abstract] [Full Text] [Related]

  • 18. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA, Van Helsdingen PJ, Kramer AE.
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [Abstract] [Full Text] [Related]

  • 19. Subsequent tumor analysis of 36 patients who have received intravesical mitomycin C for superficial bladder cancer.
    Soloway MS, Ford KS.
    J Urol; 1983 Jul; 130(1):74-8. PubMed ID: 6408268
    [Abstract] [Full Text] [Related]

  • 20. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC, Russo MA, deVere White RW.
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.